Clover Health Investments, Corp. (CLOV)

Clover Health Investments experienced significant insider selling over the past ninety days, totaling approximately 1.25 million dollars in net value. Executives initiated forty transactions, exclusively sales, following a positive earnings report. Despite recent stock price volatility, leadership continues divesting shares, reflecting a trend of liquidation among key personnel within this healthcare firm.
Ticker: CLOV Exchange: NSM


Loading...
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Clover Health Investments, Corp.. Upgrade to see score, net flow, insiders and the full signal context.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Toy Andrew Chief Executive Officer Executive Director
Transaction date
Sale
Price
29.44
Quantity 86,149 +40.6%
Value US$2,666,223
Andrew Toy Officer Officer
Transaction date
Proposed sale
Price
67.82
Quantity 66,687
Value US$61,475
1.9
BRADY PRIEST Former Officer Officer
Transaction date
Proposed sale
Price
400.43
Quantity 34,278
Value US$952,635
Reynoso Jamie L. CEO, Medicare Advantage Officer
Transaction date
Planned sale
Price
4.56
Quantity 1,000 -0.1%
Value US$100,000
JAMIE REYNOSO Officer Officer
Transaction date
Proposed sale
Price
4.56
Quantity 1,000
Value US$100,000
OLDAKOWSKI JOSEPH FRANK VP OF FINANCE AND CONTROLLER Officer
Transaction date
Sale
Price
4.64
Quantity 1,000 -1.1%
Value US$100,000
Wai Conrad CEO, Counterpart Health Officer
Transaction date
Planned sale
Price
4.72
Quantity 1,000 -20.4%
Value US$100,000
3.4
Soares Karen Chief Legal Officer Officer
Transaction date
Sale
Price
4.78
Quantity 1,000 -0.4%
Value US$100,000
Reynoso Jamie L. CEO, Medicare Advantage Officer
Transaction date
Sale
Price
4.78
Quantity 1,000 -0.3%
Value US$100,000
3.4
Karen Soares Officer Officer
Transaction date
Proposed sale
Price
4.66
Quantity 1,000
Value US$100,000
Jamie Reynoso Officer Officer
Transaction date
Proposed sale
Price
4.66
Quantity 1,000
Value US$100,000
1.9
BRADY PRIEST Former Officer Officer
Transaction date
Proposed sale
Price
4.64
Quantity 1,000
Value US$100,000
WAI CONRAD Officer Officer
Transaction date
Proposed sale
Price
4.72
Quantity 1,000
Value US$100,000
OLDAKOWSKI JOSEPH FRANK VP OF FINANCE AND CONTROLLER Officer
Transaction date
Sale
Price
5.16
Quantity 1,000 -6.7%
Value US$100,000
JOSEPH OLDAKOWSKI Officer Officer
Transaction date
Proposed sale
Price
5.16
Quantity 1,000
Value US$100,000
1.9
BRADY PRIEST Officer Officer
Transaction date
Proposed sale
Price
4.15
Quantity 73,516
Value US$305,113
THORNTON JOSEPH CLAY Interim CFO Officer
Transaction date
Sale
Price
4.39
Quantity 17,775 -1.4%
Value US$78,032
Joseph Clay Thornton Officer Officer
Transaction date
Proposed sale
Price
4.27
Quantity 16,942
Value US$72,342
1.9
BRADY PRIEST Officer Officer
Transaction date
Proposed sale
Price
4.57
Quantity 474,801
Value US$2,171,597
Toy Andrew Chief Executive Officer Executive Director
Transaction date
Sale
Price
4.65
Quantity 87,798 -0.9%
Value US$408,261
Andrew Toy Officer Officer
Transaction date
Proposed sale
Price
4.57
Quantity 85,704
Value US$391,667
1.9
BRADY PRIEST Officer Officer
Transaction date
Proposed sale
Price
4.85
Quantity 441,601
Value US$2,141,989
3.4
Soares Karen Chief Legal Officer Officer
Transaction date
Planned sale
Price
4.51
Quantity 51,700 -3.3%
Value US$233,167
3.4
KAREN SOARES Officer Officer
Transaction date
Proposed sale
Price
4.62
Quantity 51,700
Value US$238,854
Reynoso Jamie L. CEO, Medicare Advantage Officer
Transaction date
Planned sale
Price
4.53
Quantity 4,839 -0.2%
Value US$21,921
JAMIE REYNOSO Officer Officer
Transaction date
Proposed sale
Price
4.40
Quantity 4,839
Value US$21,292
Toy Andrew Chief Executive Officer Executive Director
Transaction date
Sale
Price
4.67
Quantity 62,711 -0.7%
Value US$292,860
Wai Conrad CEO, Counterpart Health Officer
Transaction date
Sale
Price
4.67
Quantity 24,215 -2.1%
Value US$113,084
Reynoso Jamie L. CEO, Medicare Advantage Officer
Transaction date
Sale
Price
4.67
Quantity 13,119 -0.5%
Value US$61,266
3.4
Soares Karen Chief Legal Officer Officer
Transaction date
Sale
Price
4.67
Quantity 10,519 -0.7%
Value US$49,124
THORNTON JOSEPH CLAY Interim CFO Officer
Transaction date
Sale
Price
4.67
Quantity 4,630 -0.4%
Value US$21,622
Joseph Clay Thornton Officer Officer
Transaction date
Proposed sale
Price
4.68
Quantity 4,486
Value US$20,994
3.4
Karen Soares Officer Officer
Transaction date
Proposed sale
Price
4.68
Quantity 10,192
Value US$47,699
Jamie Reynoso Officer Officer
Transaction date
Proposed sale
Price
4.68
Quantity 12,712
Value US$59,492
Andrew Toy Officer Officer
Transaction date
Proposed sale
Price
4.68
Quantity 60,765
Value US$284,380
Conrad Wai Officer Officer
Transaction date
Proposed sale
Price
4.68
Quantity 23,463
Value US$109,807
Reynoso Jamie L. CEO, Medicare Advantage Officer
Transaction date
Planned sale
Price
4.68
Quantity 2,384 -0.1%
Value US$11,157
JAMIE REYNOSO Officer Officer
Transaction date
Proposed sale
Price
5.00
Quantity 2,384
Value US$11,920
Reynoso Jamie L. CEO, Medicare Advantage Officer
Transaction date
Sale
Price
5.26
Quantity 6,229 -0.2%
Value US$32,765
Jamie Reynoso Officer Officer
Transaction date
Proposed sale
Price
5.26
Quantity 6,229
Value US$32,765
Toy Andrew Chief Executive Officer Executive Director
Transaction date
Sale
Price
5.32
Quantity 313,476 -3.2%
Value US$1,667,692
Andrew Toy Officer Officer
Transaction date
Proposed sale
Price
5.39
Quantity 309,558
Value US$1,668,518
Reynoso Jamie L. CEO, Medicare Advantage Officer
Transaction date
Planned sale
Price
4.78
Quantity 2,360 -0.1%
Value US$11,281
JAMIE REYNOSO Officer Officer
Transaction date
Proposed sale
Price
4.94
Quantity 2,360
Value US$11,658
OLDAKOWSKI JOSEPH FRANK VP OF FINANCE AND CONTROLLER Officer
Transaction date
Sale
Price
4.86
Quantity 12,102 -3.9%
Value US$58,816
3.4
Soares Karen Chief Legal Officer Officer
Transaction date
Sale
Price
4.61
Quantity 4,681 -0.3%
Value US$21,579
Reynoso Jamie L. CEO, Medicare Advantage Officer
Transaction date
Sale
Price
4.61
Quantity 6,350 -0.2%
Value US$29,274
3.4
Karen Soares Officer Officer
Transaction date
Proposed sale
Price
4.81
Quantity 5,342
Value US$25,695
Jamie Reynoso Officer Officer
Transaction date
Proposed sale
Price
4.81
Quantity 7,556
Value US$36,344
Reynoso Jamie L. CEO, Medicare Advantage Officer
Transaction date
Planned sale
Price
4.91
Quantity 7,289 -0.3%
Value US$35,789
JAMIE REYNOSO Officer Officer
Transaction date
Proposed sale
Price
4.89
Quantity 7,289
Value US$35,643
JAMIE REYNOSO Officer Officer
Transaction date
Proposed sale
Price
4.89
Quantity 7,289
Value US$35,643
Wai Conrad CEO, Counterpart Health Officer
Transaction date
Planned sale
Price
3.99
Quantity 220,426 -13.7%
Value US$879,500
Wai Conrad Officer Officer
Transaction date
Proposed sale
Price
3.99
Quantity 220,426
Value US$880,577
2.8
CARLADENISE A EDWARDS Director Non-Executive Director
Transaction date
Proposed sale
Price
3.41
Quantity 67,160
Value US$229,130
2.8
CARLADENISE A EDWARDS Director Non-Executive Director
Transaction date
Proposed sale
Price
3.41
Quantity 67,160
Value US$229,130
4.0
Kuipers Peter J. former CFO
Transaction date
Proposed sale
Price
3.45
Quantity 886,341
Value US$3,057,876
1.9
Priest Brady Patrick CEO of Clover Care Services Officer
Transaction date
Sale
Price
3.52
Quantity 98,039 -4.6%
Value US$345,097
1.9
BRADY PRIEST Officer Officer
Transaction date
Proposed sale
Price
3.52
Quantity 98,039
Value US$345,107
Reynoso Jamie L. CEO, Medicare Advantage Officer
Transaction date
Planned sale
Price
1.91
Quantity 5,833 -0.2%
Value US$11,141
JAMIE REYNOSO Officer Officer
Transaction date
Proposed sale
Price
1.93
Quantity 5,833
Value US$11,258
1.9
Priest Brady Patrick CEO of Home Care Officer
Transaction date
Sale
Price
2.17
Quantity 175,000 -8.1%
Value US$379,750
1.9
BRADY PRIEST Officer Officer
Transaction date
Proposed sale
Price
2.17
Quantity 175,000
Value US$378,945
JAMIE REYNOSO Officer Officer
Transaction date
Proposed sale
Price
2.54
Quantity 4,597
Value US$11,676
Reynoso Jamie L. CEO, Medicare Advantage Officer
Transaction date
Planned sale
Price
2.58
Quantity 4,597 -0.2%
Value US$11,860
JAMIE REYNOSO Officer Officer
Transaction date
Proposed sale
Price
2.59
Quantity 2,102
Value US$5,444
Reynoso Jamie L. CEO, Medicare Advantage Officer
Transaction date
Planned sale
Price
2.53
Quantity 2,102 -0.1%
Value US$5,318
JAMIE REYNOSO Officer Officer
Transaction date
Proposed sale
Price
2.60
Quantity 4,913
Value US$12,774
Reynoso Jamie L. CEO, Medicare Advantage Officer
Transaction date
Planned sale
Price
2.61
Quantity 4,913 -0.2%
Value US$12,823
Reynoso Jamie L. CEO, Medicare Advantage Officer
Transaction date
Planned sale
Price
3.58
Quantity 30,385 -1.1%
Value US$108,778
JAMIE REYNOSO Officer Officer
Transaction date
Proposed sale
Price
3.68
Quantity 30,385
Value US$111,817
Reynoso Jamie L. CEO, Medicare Advantage Officer
Transaction date
Planned sale
Price
2.69
Quantity 16,514 -0.6%
Value US$44,423
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2026-10-02 2026-10-01 S Sale

Chief Executive Officer

Executive Director
86,149 +40.6%
29.44
US$2,666,223
86,149 +40.6% 29.44 US$2,666,223
2026-10-01 2026-10-01 PrS Proposed sale

Officer

Officer
66,687
67.82
US$61,475
66,687 67.82 US$61,475
2026-09-24 2026-09-24 PrS Proposed sale

Former Officer

Officer
34,278
400.43
US$952,635
34,278 400.43 US$952,635
2026-09-18 2026-09-17 PlS Planned sale

CEO, Medicare Advantage

Officer
1,000 -0.1%
4.56
US$100,000
1,000 -0.1% 4.56 US$100,000
2026-09-17 2026-09-17 PrS Proposed sale

Officer

Officer
1,000
4.56
US$100,000
1,000 4.56 US$100,000
2026-09-17 2026-09-16 S Sale

VP OF FINANCE AND CONTROLLER

Officer
1,000 -1.1%
4.64
US$100,000
1,000 -1.1% 4.64 US$100,000
2026-09-16 2026-09-16 PrS Proposed sale

Officer

Officer
1,000
4.64
US$100,000
1,000 4.64 US$100,000
2026-09-16 2026-09-15 PlS Planned sale

CEO, Counterpart Health

Officer
1,000 -20.4%
4.72
US$100,000
1,000 -20.4% 4.72 US$100,000
2026-09-15 2026-09-15 S Sale

Chief Legal Officer

Officer
1,000 -0.4%
4.78
US$100,000
1,000 -0.4% 4.78 US$100,000
2026-09-15 2026-09-15 S Sale

CEO, Medicare Advantage

Officer
1,000 -0.3%
4.78
US$100,000
1,000 -0.3% 4.78 US$100,000
2026-09-15 2026-09-15 PrS Proposed sale

Officer

Officer
1,000
4.66
US$100,000
1,000 4.66 US$100,000
2026-09-15 2026-09-15 PrS Proposed sale

Officer

Officer
1,000
4.66
US$100,000
1,000 4.66 US$100,000
2026-09-15 2026-09-15 PrS Proposed sale

Former Officer

Officer
1,000
4.64
US$100,000
1,000 4.64 US$100,000
2026-09-15 2026-09-15 PrS Proposed sale

Officer

Officer
1,000
4.72
US$100,000
1,000 4.72 US$100,000
2026-09-14 2026-09-14 S Sale

VP OF FINANCE AND CONTROLLER

Officer
1,000 -6.7%
5.16
US$100,000
1,000 -6.7% 5.16 US$100,000
2026-09-14 2026-09-14 PrS Proposed sale

Officer

Officer
1,000
5.16
US$100,000
1,000 5.16 US$100,000
2026-08-31 2026-08-31 PrS Proposed sale

Officer

Officer
73,516
4.15
US$305,113
73,516 4.15 US$305,113
2026-08-17 2026-08-17 S Sale

Interim CFO

Officer
17,775 -1.4%
4.39
US$78,032
17,775 -1.4% 4.39 US$78,032
2026-08-17 2026-08-17 PrS Proposed sale

Officer

Officer
16,942
4.27
US$72,342
16,942 4.27 US$72,342
2026-08-14 2026-08-14 PrS Proposed sale

Officer

Officer
474,801
4.57
US$2,171,597
474,801 4.57 US$2,171,597
2026-08-10 2026-08-10 S Sale

Chief Executive Officer

Executive Director
87,798 -0.9%
4.65
US$408,261
87,798 -0.9% 4.65 US$408,261
2026-08-10 2026-08-10 PrS Proposed sale

Officer

Officer
85,704
4.57
US$391,667
85,704 4.57 US$391,667
2026-08-07 2026-08-07 PrS Proposed sale

Officer

Officer
441,601
4.85
US$2,141,989
441,601 4.85 US$2,141,989
2026-07-20 2026-07-20 PlS Planned sale

Chief Legal Officer

Officer
51,700 -3.3%
4.51
US$233,167
51,700 -3.3% 4.51 US$233,167
2026-07-20 2026-07-20 PrS Proposed sale

Officer

Officer
51,700
4.62
US$238,854
51,700 4.62 US$238,854
2026-07-17 2026-07-17 PlS Planned sale

CEO, Medicare Advantage

Officer
4,839 -0.2%
4.53
US$21,921
4,839 -0.2% 4.53 US$21,921
2026-07-17 2026-07-17 PrS Proposed sale

Officer

Officer
4,839
4.40
US$21,292
4,839 4.40 US$21,292
2026-07-16 2026-07-15 S Sale

Chief Executive Officer

Executive Director
62,711 -0.7%
4.67
US$292,860
62,711 -0.7% 4.67 US$292,860
2026-07-16 2026-07-15 S Sale

CEO, Counterpart Health

Officer
24,215 -2.1%
4.67
US$113,084
24,215 -2.1% 4.67 US$113,084
2026-07-16 2026-07-15 S Sale

CEO, Medicare Advantage

Officer
13,119 -0.5%
4.67
US$61,266
13,119 -0.5% 4.67 US$61,266
2026-07-16 2026-07-15 S Sale

Chief Legal Officer

Officer
10,519 -0.7%
4.67
US$49,124
10,519 -0.7% 4.67 US$49,124
2026-07-16 2026-07-15 S Sale

Interim CFO

Officer
4,630 -0.4%
4.67
US$21,622
4,630 -0.4% 4.67 US$21,622
2026-07-15 2026-07-15 PrS Proposed sale

Officer

Officer
4,486
4.68
US$20,994
4,486 4.68 US$20,994
2026-07-15 2026-07-15 PrS Proposed sale

Officer

Officer
10,192
4.68
US$47,699
10,192 4.68 US$47,699
2026-07-15 2026-07-15 PrS Proposed sale

Officer

Officer
12,712
4.68
US$59,492
12,712 4.68 US$59,492
2026-07-15 2026-07-15 PrS Proposed sale

Officer

Officer
60,765
4.68
US$284,380
60,765 4.68 US$284,380
2026-07-15 2026-07-15 PrS Proposed sale

Officer

Officer
23,463
4.68
US$109,807
23,463 4.68 US$109,807
2026-07-09 2026-07-08 PlS Planned sale

CEO, Medicare Advantage

Officer
2,384 -0.1%
4.68
US$11,157
2,384 -0.1% 4.68 US$11,157
2026-07-08 2026-07-08 PrS Proposed sale

Officer

Officer
2,384
5.00
US$11,920
2,384 5.00 US$11,920
2026-07-06 2026-07-06 S Sale

CEO, Medicare Advantage

Officer
6,229 -0.2%
5.26
US$32,765
6,229 -0.2% 5.26 US$32,765
2026-07-06 2026-07-06 PrS Proposed sale

Officer

Officer
6,229
5.26
US$32,765
6,229 5.26 US$32,765
2026-07-01 2026-07-01 S Sale

Chief Executive Officer

Executive Director
313,476 -3.2%
5.32
US$1,667,692
313,476 -3.2% 5.32 US$1,667,692
2026-07-01 2026-07-01 PrS Proposed sale

Officer

Officer
309,558
5.39
US$1,668,518
309,558 5.39 US$1,668,518
2026-06-18 2026-06-17 PlS Planned sale

CEO, Medicare Advantage

Officer
2,360 -0.1%
4.78
US$11,281
2,360 -0.1% 4.78 US$11,281
2026-06-17 2026-06-17 PrS Proposed sale

Officer

Officer
2,360
4.94
US$11,658
2,360 4.94 US$11,658
2026-06-17 2026-06-16 S Sale

VP OF FINANCE AND CONTROLLER

Officer
12,102 -3.9%
4.86
US$58,816
12,102 -3.9% 4.86 US$58,816
2026-06-16 2026-06-16 PrS Proposed sale

Officer

Officer
14,155
4.94
US$69,926
14,155 4.94 US$69,926
2026-06-16 2026-06-15 S Sale

Chief Legal Officer

Officer
4,681 -0.3%
4.61
US$21,579
4,681 -0.3% 4.61 US$21,579
2026-06-16 2026-06-15 S Sale

CEO, Medicare Advantage

Officer
6,350 -0.2%
4.61
US$29,274
6,350 -0.2% 4.61 US$29,274
2026-06-15 2026-06-15 PrS Proposed sale

Officer

Officer
5,342
4.81
US$25,695
5,342 4.81 US$25,695
2026-06-15 2026-06-15 PrS Proposed sale

Officer

Officer
7,556
4.81
US$36,344
7,556 4.81 US$36,344
2026-06-11 2026-06-11 PlS Planned sale

CEO, Medicare Advantage

Officer
7,289 -0.3%
4.91
US$35,789
7,289 -0.3% 4.91 US$35,789
2026-06-11 2026-06-11 PrS Proposed sale

Officer

Officer
7,289
4.89
US$35,643
7,289 4.89 US$35,643
2026-06-11 2026-06-11 PrS Proposed sale

Officer

Officer
7,289
4.89
US$35,643
7,289 4.89 US$35,643
2026-05-28 2026-05-28 PlS Planned sale

CEO, Counterpart Health

Officer
220,426 -13.7%
3.99
US$879,500
220,426 -13.7% 3.99 US$879,500
2026-05-28 2026-05-28 PrS Proposed sale

Officer

Officer
220,426
3.99
US$880,577
220,426 3.99 US$880,577
2026-05-19 2026-05-18 S Sale Non-Executive Director
67,160 -19.0%
3.42
US$229,687
67,160 -19.0% 3.42 US$229,687
2026-05-18 2026-05-18 PrS Proposed sale

Director

Non-Executive Director
67,160
3.41
US$229,130
67,160 3.41 US$229,130
2026-05-18 2026-05-18 PrS Proposed sale

Director

Non-Executive Director
67,160
3.41
US$229,130
67,160 3.41 US$229,130
2026-05-14 2026-05-14 PrS Proposed sale

former CFO

886,341
3.45
US$3,057,876
886,341 3.45 US$3,057,876
2026-05-13 2026-05-13 S Sale

CEO of Clover Care Services

Officer
98,039 -4.6%
3.52
US$345,097
98,039 -4.6% 3.52 US$345,097
2026-05-13 2026-05-13 PrS Proposed sale

Officer

Officer
98,039
3.52
US$345,107
98,039 3.52 US$345,107
2026-03-18 2026-03-18 PlS Planned sale

CEO, Medicare Advantage

Officer
5,833 -0.2%
1.91
US$11,141
5,833 -0.2% 1.91 US$11,141
2026-03-18 2026-03-18 PrS Proposed sale

Officer

Officer
5,833
1.93
US$11,258
5,833 1.93 US$11,258
2026-03-05 2026-03-04 S Sale

CEO of Home Care

Officer
175,000 -8.1%
2.17
US$379,750
175,000 -8.1% 2.17 US$379,750
2026-03-04 2026-03-04 PrS Proposed sale

Officer

Officer
175,000
2.17
US$378,945
175,000 2.17 US$378,945
2026-01-20 2026-01-20 PrS Proposed sale

Officer

Officer
4,597
2.54
US$11,676
4,597 2.54 US$11,676
2026-01-20 2026-01-20 PlS Planned sale

CEO, Medicare Advantage

Officer
4,597 -0.2%
2.58
US$11,860
4,597 -0.2% 2.58 US$11,860
2026-01-07 2026-01-07 PrS Proposed sale

Officer

Officer
2,102
2.59
US$5,444
2,102 2.59 US$5,444
2026-01-07 2026-01-07 PlS Planned sale

CEO, Medicare Advantage

Officer
2,102 -0.1%
2.53
US$5,318
2,102 -0.1% 2.53 US$5,318
2025-12-18 2025-12-18 PrS Proposed sale

Officer

Officer
4,913
2.60
US$12,774
4,913 2.60 US$12,774
2025-12-18 2025-12-18 PlS Planned sale

CEO, Medicare Advantage

Officer
4,913 -0.2%
2.61
US$12,823
4,913 -0.2% 2.61 US$12,823
2025-11-05 2025-11-04 PlS Planned sale

CEO, Medicare Advantage

Officer
30,385 -1.1%
3.58
US$108,778
30,385 -1.1% 3.58 US$108,778
2025-11-04 2025-11-04 PrS Proposed sale

Officer

Officer
30,385
3.68
US$111,817
30,385 3.68 US$111,817
2025-10-21 2025-10-17 PlS Planned sale

CEO, Medicare Advantage

Officer
16,514 -0.6%
2.69
US$44,423
16,514 -0.6% 2.69 US$44,423